Dr Garmezy on Factors Influencing Treatment Selection in Variant RCC
Benjamin Garmezy, MD, discusses key factors influencing treatment selection for patients with variant renal cell carcinoma.
Source: onclive.com
Genitourinary Research News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Genitourinary Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Genitourinary Research Today - Breaking & Trending Today
Dr Garmezy on Choosing an IO/TKI Treatment Regimen in ccRCC
Benjamin Garmezy, MD, discusses in when to choose an IO/TKI regimen for the treatment of patients with ccRCC.
Source: onclive.com
Dr Garmezy on the Impact of Combination Regimens on Outcomes and Quality of Life in Patients With RCC
Benjamin Garmezy, MD, discusses the impact of frontline combination regimens on patient outcomes in patients with renal cell carcinoma.
Source: onclive.com
Garmezy Highlights Ongoing and Future Research Directions Across RCC Subtypes
Benjamin Garmezy, MD, provides an overview of recent data on immuno-oncology/TKI combination data in variant renal cell carcinoma.
Source: onclive.com
Individualized Approach Best Informs Choice of Frontline Immunotherapy or Targeted Therapy Combinations Across RCC Histologies
Benjamin Garmezy, MD, discusses challenges associated with navigating the current frontline armamentarium in both clear cell and variant RCC, the impact of frontline IO doublets and IO/TKI regimens on patient outcomes, and the importance of ongoing combination studies for patients with variant RCC.
Source: onclive.com